Epstein Barr Virus and Atrial Fibrillation

A Causal Link?

  • Ilija Barukcic Internist, Germany
Keywords: Epstein-Barr virus, atrial fibrillation, causal relationship


Objective: Atrial fibrillation (AF) is very frequent and clinically significant arrhythmia. The incidence of atrial fibrillation is continuously rising. Meanwhile several risk factors for AF development have been identified but the etiology is not cleared.

Methods: A systematic review and re-analysis of studies which investigated the relationship between AF and some risk factors was conducted. The method of the conditio sine qua non relationship, the method of the conditio per quam relationship, the method of the exclusion relationship and the mathematical formula of the causal relationship k were used to proof the hypothesis. Significance was indicated by a p-value of less than 0.05.

Results: The studies analyzed were able to provide direct and indirect evidence that AF is caused by a process of inflammation while a direct identification of the factor causing AF was not possible. Still, it appears to be very probable that Epstein-Barr virus (EBV) is the cause of AF. 

Conclusion: Atrial fibrillation (AF) appears to be caused by an EBV inflammatory process.


Aghenta, A., Osowo, A., & Thomas, J. (2008). Symptomatic atrial fibrillation with infectious mononucleosis Canadian Family Physician Medecin De Famille Canadien, 54(5), 695-696. Retrieved from http://www.cfp.ca/content/54/5/695.long
Anderson, J. L., Allen Maycock, C. A., Lappé, D. L., Crandall, B. G., Horne, B. D., Bair, T. L., … Muhlestein, J. B. (2004). Frequency of elevation of C-reactive protein in atrial fibrillation The American Journal of Cardiology, 94, 1255-1259. https://doi.org/10.1016/j.amjcard.2004.07.108
Antonakaki, D., Mirza, S. A., Sundar, S., & Grapsa, J. (2016). Epstein-Barr futile myocarditis requiring urgent orthotopic heart transplantation Perfusion, 31, 431-432. https://doi.org/10.1177/0267659115618460
Arens, M., & Travis, S. (2000). Zinc salts inactivate clinical isolates of herpes simplex virus in vitro Journal of Clinical Microbiology, 38(5), 1758-1762. https://jcm.asm.org/content/38/5/1758.long
Armitage, P., & Colton, T. (Eds.). (2005). Encyclopedia of biostatistics (2nd ed.). Chichester, West Sussex, England, Hoboken, NJ: John Wiley.
Asselbergs, F. W., van den Berg, M. P., Diercks, G. F. H., van Gilst, W. H., & van Veldhuisen, D. J. (2005). C-reactive protein and microalbuminuria are associated with atrial fibrillation International Journal of Cardiology, 98, 73-77. https://doi.org/10.1016/j.ijcard.2003.12.028
Aviles, R. J., Martin, D. O., Apperson-Hansen, C., Houghtaling, P. L., Rautaharju, P., Kronmal, R. A., … Chung, M. K. (2003). Inflammation as a risk factor for atrial fibrillation Circulation, 108, 3006-3010. https://doi.org/10.1161/01.CIR.0000103131.70301.4F
Bacani, A. K., Crowson, C. S., Roger, V. L., Gabriel, S. E., & Matteson, E. L. (2015). Increased incidence of atrial fibrillation in patients with rheumatoid arthritis BioMed Research International, 2015, 809514. https://doi.org/10.1155/2015/809514
Barukčić, I. (1989). Die Kausalität (1. Aufl.). Hamburg: Wiss.-Verl.
Barukčić, I. (1997). Die Kausalität (2., völlig überarb. Aufl.). Wilhelmshaven: Scientia.
Barukčić, I. (2005). Causality: New statistical methods. Norderstedt, Germany: Books on Demand GmbH.
Barukčić, I. (2005). Causality: New statistical methods. Norderstedt, Germany: Books on Demand GmbH.
Barukčić, I. (2006). Causality: New statistical methods (2. Aufl.). Norderstedt: Books on Demand.
Barukčić, I. (2006). New Method for Calculating Causal Relationships XXIIIrd International Biometric Conference, Montréal, Québec, Canada, July 16-21, 2006, 23, 49. Retrieved from http://www.medicine.mcgill.ca/epidemiology/hanley/ibc2006program.pdf
Barukčić, I. (2016). The Mathematical Formula of the Causal Relationship k International Journal of Applied Physics and Mathematics, 6, 45-65. https://doi.org/10.17706/ijapm.2016.6.2.45-65
Barukčić, I. (2017). Die Kausalität. Norderstedt: Books on Demand.
Barukčić, I. (2017). Helicobacter pylori—The Cause of Human Gastric Cancer Journal of Biosciences and Medicines, 5, 1-9. https://doi.org/10.4236/jbm.2017.52001
Barukčić, I. (2017). Theoriae causalitatis principia mathematica. Norderstedt: Books on Demand.
Barukčić, I. (2018). Epstein Bar Virus—The Cause of Hodgkin’s Lymphoma Journal of Biosciences and Medicines, 6, 75-100. https://doi.org/10.4236/jbm.2018.61008
Barukčić, I. (2018). Fusobacterium nucleatum —The Cause of Human Colorectal Cancer Journal of Biosciences and Medicines, 6, 31-69. https://doi.org/10.4236/jbm.2018.63004
Barukčić, I. (2018). Gastric Cancer and Epstein-Barr Virus Infection Modern Health Science, 1, 1-18. https://doi.org/10.30560/mhs.v1n2p1
Barukčić, I. (2018). Helicobacter Pylori is the Cause of Gastric Cancer Modern Health Science, 1, 43-50. https://doi.org/10.30560/mhs.v1n1p43
Barukčić, I. (2018). Human Cytomegalovirus is the Cause of Glioblastoma Multiforme Modern Health Science, 1, p19. https://doi.org/10.30560/mhs.v1n2p19
Barukčić, I. (2018). Human Papillomavirus—The Cause of Human Cervical Cancer Journal of Biosciences and Medicines, 6, 106-125. https://doi.org/10.4236/jbm.2018.64009
Barukčić, I. (2018). Mycobacterium Avium Subspecies Paratuberculosis: The Cause Of Croh's Disease. Modern Health Science, 1, 19-34. https://doi.org/10.30560/mhs.v1n1p19
Barukčić, K., & Barukčić, I. (2016). Epstein Barr Virus—The Cause of Multiple Sclerosis Journal of Applied Mathematics and Physics, 4, 1042-1053. https://doi.org/10.4236/jamp.2016.46109
Barukčić, K., Barukčić, J. P., Barukčić, I. (2018). Epstein Barr Virus Is The Cause of Rheumaotid Arthritis Romanian Journal of Rheumatology, 28(4), 148-163. https://rjr.com.ro/
Beard, J. A., Bearden, A., & Striker, R. (2011). Vitamin D and the anti-viral state Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology, 50, 194-200. https://doi.org/10.1016/j.jcv.2010.12.006
Benjamin, E. J., Levy, D., Vaziri, S. M., D'Agostino, R. B., Belanger, A. J., & Wolf, P. A. (1994). Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study JAMA, 271(11), 840-844. https://doi.org/10.1001/jama.1994.03510350050036
Bissell, M. J., Hatie, C., Farson, D. A., Schwarz, R. I., & Soo, W. J. (1980). Ascorbic acid inhibits replication and infectivity of avian RNA tumor virus Proceedings of the National Academy of Sciences of the United States of America, 77(5), 2711-2715. https://doi.org/10.1073/pnas.77.5.2711
Bolboacă, S. D., Jäntschi, L., Sestraş, A. F., Sestraş, R. E., & Pamfil, D. C. (2011). Pearson-Fisher Chi-Square Statistic Revisited Information, 2, 528-545. https://doi.org/10.3390/info2030528
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B.,. . . Schnitzer, T. J. (2000). Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group The New England Journal of Medicine, 343, 1520-8, 2 p following 1528. https://doi.org/10.1056/NEJM200011233432103
Centers for Disease Control and Prevention. (2018). Epstein-Barr Virus and Infectious Mononucleosis. Laboratory Testing. National Center for Immunization and Respiratory Diseases. Retrieved from https://www.cdc.gov/epstein-barr/index.html
Cha, M. J., Seo, H. M., Choi, E. K., Lee, J. H., Han, K., Lee, S. R., … Oh, S. (2018). Increased Risk of Atrial Fibrillation in the Early Period after Herpes Zoster Infection: a Nationwide Population-based Case-control Study Journal of Korean Medical Science, 33, e160. https://doi.org/10.3346/jkms.2018.33.e160
Chao, T. F., Liu, C. J., Lin, Y. J., Chang, S. L., Lo, L. W., Hu, Y. F., … Chen, S. A. (2018). Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study Circulation, 138, 37-47. https://doi.org/10.1161/CIRCULATIONAHA.117.031658
Chen, J. Y., Chang, C. Y., Feng, P. H., Chu, C. C., So, E. C., & Hu, M.-L. (2009). Plasma vitamin C is lower in postherpetic neuralgia patients and administration of vitamin C reduces spontaneous pain but not brush-evoked pain The Clinical Journal of Pain, 25, 562-569. https://doi.org/10.1097/AJP.0b013e318193cf32
Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., … Murray, C. J. L. (2014). Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study Circulation, 129, 837-847. https://doi.org/10.1161/CIRCULATIONAHA.113.005119
Cohen, J. I. (2000). Epstein-Barr virus infection The New England Journal of Medicine, 343, 481-492. https://doi.org/10.1056/NEJM200008173430707
Conway, D. S. g., Buggins, P., Hughes, E., & Lip, G. Y. H. (2004). Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation American Heart Journal, 148, 462-466. https://doi.org/10.1016/j.ahj.2004.01.026
Dernellis, J., & Panaretou, M. (2004). Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation European Heart Journal, 25, 1100-1107. https://doi.org/10.1016/j.ehj.2004.04.025
Engelmann, M. D. M., & Svendsen, J. H. (2005). Inflammation in the genesis and perpetuation of atrial fibrillation European Heart Journal, 26, 2083-2092. https://doi.org/10.1093/eurheartj/ehi350
EPSTEIN, M. A., ACHONG, B. G., & BARR, Y. M. (1964). Virus particles in cultured lymphoblasts from Burkitt's lymphoma Lancet (London, England), 1(7335), 702-703. https://doi.org/10.1016/S0140-6736(64)91524-7
Fox, C. S., Parise, H., D'Agostino, R. B., Lloyd-Jones, D. M., Vasan, R. S., Wang, T. J., ... Benjamin, E. J. (2004). Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring JAMA, 291, 2851-2855. https://doi.org/10.1001/jama.291.23.2851
Furuya, A., Uozaki, M., Yamasaki, H., Arakawa, T., Arita, M., & Koyama, A. H. (2008). Antiviral effects of ascorbic and dehydroascorbic acids in vitro International Journal of Molecular Medicine, 22(4), 541-545. https://doi.org/10.3892/ijmm_00000053
Gill, H., Hwang, Y.-Y., Chan, T. S. Y., Pang, A. W. K., Leung, A. Y. H., Tse, E., & Kwong, Y. L. (2014). Valganciclovir suppressed Epstein Barr virus reactivation during immunosuppression with alemtuzumab Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology, 59, 255-258. https://doi.org/10.1016/j.jcv.2014.01.005
Glotzer, T. V., & Ziegler, P. D. (2013). Silent atrial fibrillation as a stroke risk factor and anticoagulation indication The Canadian Journal of Cardiology, 29, S14-23. https://doi.org/10.1016/j.cjca.2013.03.023
Hanley, J. A. (1983). If Nothing Goes Wrong, Is Everything All Right? JAMA, 249, 1743. https://doi.org/10.1001/jama.1983.03330370053031
Henningsen, K. M. A., Therkelsen, S. K., Bruunsgaard, H., Krabbe, K. S., Pedersen, B. K., & Svendsen, J. H. (2009). Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion Scandinavian Journal of Clinical and Laboratory Investigation, 69, 425-432. https://doi.org/10.1080/00365510802676848
Hirano, T., Murakami, M., Fukada, T., Nishida, K., Yamasaki, S., & Suzuki, T. (2008). Roles of zinc and zinc signaling in immunity: zinc as an intracellular signaling molecule Advances in Immunology, 97, 149-176. https://doi.org/10.1016/S0065-2776(08)00003-5
Hung, Y. M., Lin, L., Chen, C. M., Chiou, J. Y., Wang, Y. H., Wang, P. Y. P., & Wei, J. C. C. (2017). The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study PloS One, 12, e0179081. https://doi.org/10.1371/journal.pone.0179081
Issac, T. T., Dokainish, H., & Lakkis, N. M. (2007). Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data Journal of the American College of Cardiology, 50, 2021-2028. https://doi.org/10.1016/j.jacc.2007.06.054
Isserlis, L. (1918). On the Value of a Mean as Calculated from a Sample Journal of the Royal Statistical Society, 81, 75. https://doi.org/10.2307/2340569
Jovanovic, B. D., & Levy, P. S. (1997). A Look at the Rule of Three The American Statistician, 51, 137-139. https://doi.org/10.1080/00031305.1997.10473947
Kawabe, A., Nakano, K., Miyata, H., Shibuya, R., Matsuyama, A., Ogoshi, T., & Tanaka, Y. (2018). Fatal Chronic Active Epstein-Barr Virus Infection in a Rheumatoid Arthritis Patient Treated with Abatacept Internal Medicine (Tokyo, Japan). Advance online publication. https://doi.org/10.2169/internalmedicine.1280-18
Kim, M. H., Johnston, S. S., Chu, B. C., Dalal, M. R., & Schulman, K. L. (2011). Estimation of total incremental health care costs in patients with atrial fibrillation in the United States Circulation. Cardiovascular Quality and Outcomes, 4, 313-320. https://doi.org/10.1161/CIRCOUTCOMES.110.958165
Kim, S. C., Liu, J., & Solomon, D. H. (2014). The risk of atrial fibrillation in patients with rheumatoid arthritis Annals of the Rheumatic Diseases, 73, 1091-1095. https://doi.org/10.1136/annrheumdis-2013-203343
Kirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., … Camm, A. J. (2013). Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 15, 1540-1556. https://doi.org/10.1093/europace/eut232
Kirchhof, P., Lip, G. Y. H., van Gelder, I. C., Bax, J., Hylek, E., Kaab, S., ... Camm, A. J. (2012). Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 14, 8-27. https://doi.org/10.1093/europace/eur241
Klutts, J. S., Ford, B. A., Perez, N. R., & Gronowski, A. M. (2009). Evidence-based approach for interpretation of Epstein-Barr virus serological patterns Journal of Clinical Microbiology, 47, 3204-3210. https://doi.org/10.1128/JCM.00164-09
Kocher, M. S., & Zurakowski, D. (2004). Clinical epidemiology and biostatistics: a primer for orthopaedic surgeons The Journal of Bone and Joint Surgery. American Volume, 86-A(3), 607-620. https://insights.ovid.com/pubmed?pmid=14996892
Kolmogoroff, A. (1933). Grundbegriffe der Wahrscheinlichkeitsrechnung. Berlin, Heidelberg: Springer Berlin Heidelberg.
Korantzopoulos, P., Kolettis, T., Siogas, K., & Goudevenos, J. (2003). Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 9(9), RA225-9. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12960937
Krumholz, H. M., Ross, J. S., Presler, A. H., & Egilman, D. S. (2007). What have we learnt from Vioxx? BMJ (Clinical Research Ed.), 334, 120-123. https://doi.org/10.1136/bmj.39024.487720.68
LANCASTER, H. O., & Seneta, E. (2005). Chi-Square Distribution. In P. Armitage & T. Colton (Eds.), Encyclopedia of biostatistics (2nd ed.). Chichester, West Sussex, England, Hoboken, NJ: John Wiley. https://doi.org/10.1002/0470011815.b2a15018
Leemis, L. M., & Trivedi, K. S. (1996). A Comparison of Approximate Interval Estimators for the Bernoulli Parameter The American Statistician, 50, 63. https://doi.org/10.2307/2685046
Lerner, A. M., Beqaj, S. H., Deeter, R. G., & Fitzgerald, J. T. (2007). Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up In Vivo (Athens, Greece), 21(5), 707-713. https://www.ncbi.nlm.nih.gov/pubmed/18019402
Lindhardsen, J., Ahlehoff, O., Gislason, G. H., Madsen, O. R., Olesen, J. B., Svendsen, J. H., ... Hansen, P. R. (2012). Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study BMJ (Clinical Research Ed.), 344, e1257. https://doi.org/10.1136/bmj.e1257
Liu, T., Li, G., Li, L., & Korantzopoulos, P. (2007). Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis Journal of the American College of Cardiology, 49, 1642-1648. https://doi.org/10.1016/j.jacc.2006.12.042
Louis, T. A. (1981). Confidence Intervals for a Binomial Parameter after Observing No Successes The American Statistician, 35, 154. https://doi.org/10.1080/00031305.1981.10479337
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y. H., & Murray, E. (2007). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial The Lancet, 370, 493-503. https://doi.org/10.1016/S0140-6736(07)61233-1
Mikirova, N., & Hunninghake, R. (2014). Effect of high dose vitamin C on Epstein-Barr viral infection Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 20, 725-732. https://doi.org/10.12659/MSM.890423
Mikirova, N., Casciari, J., Riordan, N., & Hunninghake, R. (2013). Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients Journal of Translational Medicine, 11, 191. https://doi.org/10.1186/1479-5876-11-191
Mocchegiani, E., & Muzzioli, M. (2000). Therapeutic application of zinc in human immunodeficiency virus against opportunistic infections The Journal of Nutrition, 130, 1424S-31S. https://doi.org/10.1093/jn/130.5.1424S
Nystad, T. W., & Myrmel, H. (2007). Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology, 38, 292–297. https://doi.org/10.1016/j.jcv.2007.01.006
Odumade, O. A., Hogquist, K. A., & Balfour, H. H. (2011). Progress and problems in understanding and managing primary Epstein-Barr virus infections Clinical Microbiology Reviews, 24, 193-209. https://doi.org/10.1128/CMR.00044-10
Pearson, K. (1900). X. On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling The London, Edinburgh, and Dublin Philosophical Magazine and Journal of Science, 50, 157-175. https://doi.org/10.1080/14786440009463897
Psaty, B. M., Manolio, T. A., Kuller, L. H., Kronmal, R. A., Cushman, M., Fried, L. P., ... Rautaharju, P. M. (1997). Incidence of and risk factors for atrial fibrillation in older adults Circulation, 96(7), 2455-2461. https://www.ncbi.nlm.nih.gov/pubmed/9337224
Riordan, H. D., Hunninghake, R. B., Riordan, N. H., Jackson, J. J., Meng, X., Taylor, P., … Rivera, A. (2003). Intravenous ascorbic acid: protocol for its application and use Puerto Rico Health Sciences Journal, 22(3), 287-290. https://www.ncbi.nlm.nih.gov/pubmed/14619456
Roxby, A. C., Atkinson, C., Asbjörnsdóttir, K., Farquhar, C., Kiarie, J. N., Drake, A. L., … Slyker, J. A. (2014). Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women PloS One, 9, e87855. https://doi.org/10.1371/journal.pone.0087855
Ruiz Espejo, M. (2007). Review of Causality: New Statistical Methods, 2nd edn (by Ilija Barukcic; Books on Demand, Norderstedt DE, 2006): 34: 1013-1014 Journal of Applied Statistics, 34, 1013-1014. https://doi.org/10.1080/02664760701590707
Rumke, C. L. (1975). Implications of the Statement: No Side Effects Were Observed The New England Journal of Medicine, 292, 372-373. https://doi.org/10.1056/NEJM197502132920723
Savelieva, I., & Camm, A. J. (2000). Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing, 4(2), 369-382. https://www.ncbi.nlm.nih.gov/pubmed/10936003
Shankar, A. H., & Prasad, A. S. (1998). Zinc and immune function: the biological basis of altered resistance to infection The American Journal of Clinical Nutrition, 68, 447S-463S. https://doi.org/10.1093/ajcn/68.2.447S
Sibbald, B. (2004). Rofecoxib (Vioxx) voluntarily withdrawn from market CMAJ: Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne, 171, 1027-1028. https://doi.org/10.1503/cmaj.1041606
Şimşek, B., Altay, S., Özbilgin, N., & Onat, A. (2018). Autoimmune activation as a determinant of atrial fibrillation among Turks: A prospective evaluation Medicine, 97, e11779. https://doi.org/10.1097/MD.0000000000011779
Slomiany, B. L., & Slomiany, A. (2017). Role of LPS-elicited signaling in triggering gastric mucosal inflammatory responses to H. pylori: modulatory effect of ghrelin Inflammopharmacology, 25, 415-429. https://doi.org/10.1007/s10787-017-0360-1
Slomiany, B. L., & Slomiany, A. (2018). Helicobacter pylori LPS-induced gastric mucosal spleen tyrosine kinase (Syk) recruitment to TLR4 and activation occurs with the involvement of protein kinase Cδ Inflammopharmacology, 26, 805-815. https://doi.org/10.1007/s10787-017-0430-4
Stroke Risk in Atrial Fibrillation Working Group. (2007). Independent predictors of stroke in patients with atrial fibrillation: a systematic review Neurology, 69, 546-554. https://doi.org/10.1212/01.wnl.0000267275.68538.8d
Takano, H., Nakagawa, K., Ishio, N., Daimon, M., Daimon, M., Kobayashi, Y., … Komuro, I. (2008). Active myocarditis in a patient with chronic active Epstein-Barr virus infection International Journal of Cardiology, 130, e11-3. https://doi.org/10.1016/j.ijcard.2007.07.040
Thompson, M. E. (2006). Ilija Barukčić. Causality. New Statistical Methods. A Book Review. International Statistical Institute - Short Book Review, 26(1), 6. Retrieved from http://isi.cbs.nl/sbr/images/V26-1_Apr06.pdf
Wang, D. Z., Chen, W., Yang, S., Wang, J., Li, Q., Fu, Q., ... Chen, B. X. (2015). Helicobacter pylori infection in Chinese patients with atrial fibrillation Clinical Interventions in Aging, 10, 813-819. https://doi.org/10.2147/CIA.S72724
Wasmer, K., Eckardt, L., & Breithardt, G. (2017). Predisposing factors for atrial fibrillation in the elderly Journal of Geriatric Cardiology: JGC, 14, 179-184. https://doi.org/10.11909/j.issn.1671-5411.2017.03.010
Wooten, M. D., Reddy, G. V., & Johnson, R. D. (2000). Atrial fibrillation occurring in a patient taking etanercept plus methotrexate for rheumatoid arthritis Delaware Medical Journal, 72(12), 517-519. https://www.ncbi.nlm.nih.gov/pubmed/11200291
Yamane, T. (Ed.). (1964). Statistics. An introductory analysis: Harper International Edition.
Yates, F. (1934). Contingency Tables Involving Small Numbers and the χ 2 Test Supplement to the Journal of the Royal Statistical Society, 1, 217. https://doi.org/10.2307/2983604
Therapeutic schema to cure atrial fibrillation (experimental; not verified by trials; Don’t use without doctor’s advise!!!)